Biochemical and Pharmacological Characterizations of ESI-09 Based EPAC Inhibitors: Defining the ESI-09 "Therapeutic Window"

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhu, Yingmin ^a   Chen, Haijun ^b,d   Boulton, Stephen ^c   Mei, Fang ^a   Ye, Na ^b   Melacini, Giuseppe ^c   Zhou, Jia ^b   Cheng, Xiaodong ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d FUZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3-(5-TERT-BUTYLISOXAZOL-3-YL)-2-((3-CHLOROPHENYL)HYDRAZONO)-3-OXOPROPIONITRILE; ACETYLCYSTEINE; ERYTHROMYCIN; ERYTHROMYCIN PROPIONATE-N-ACETYLCYSTEINATE; HYDRAZONE DERIVATIVE; ISOXAZOLE DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; KNOCKOUT MOUSE; MOUSE; STRUCTURE ACTIVITY RELATION;

ACETYLCYSTEINE; ANIMALS; ERYTHROMYCIN; HYDRAZONES; ISOXAZOLES; MICE; MICE, KNOCKOUT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84925424433     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09344     Document Type: Article

References (42)

1. Berman, H. M. et al. The cAMP binding domain: an ancient signaling module. Proc Natl Acad Sci U S A 102, 45-50 (2005).
2. Cheng, X., Ji, Z., Tsalkova, T. & Mei, F. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 40, 651-662 (2008).
3. Craven, K. B. & Zagotta, W. N. CNG and HCN channels: two peas, one pod. Annu Rev Physiol 68, 375-401 (2006).
4. de Rooij, J. et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477 (1998).
5. Kawasaki, H. et al. A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279 (1998).
6. Mei, F. et al. Differential signaling of cyclic AMP - Opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277, 11497-11504 (2002).
7. Niimura, M. et al. Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol 219, 652-658 (2009).
8. Liu, C. et al. The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope. Mol Cell Biol 30, 3956-3969 (2010).
9. Gloerich, M. et al. Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Mol Cell Biol 30, 5421-5431 (2010).
10. Gloerich, M. et al. The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. J Cell Biol 193, 1009-1020 (2011).
11. Yan, J. et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol 33, 918-926 (2013).
12. Pereira, L. et al. Epac2 mediates cardiac beta1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation 127, 913-922 (2013).
13. Wang, H. et al. Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain. J Clin Invest 123, 5023-5034 (2013).
14. Okumura, S. et al. Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses. J Clin Invest 124, 2785-2801 (2014).
15. Onodera, Y. Nam, J. M. & Bissell, M. J. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest 124, 367-384 (2014).
16. Almahariq, M. Mei, F. C. & Cheng, X. Cyclic AMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol Metab 25, 60-71 (2014).
17. Tsalkova, T. Mei, F. C. & Cheng, X. A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists. PLoS One 7, e30441 (2012).
18. Tsalkova, T. et al. Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc Natl Acad Sci U S A 109, 18613-18618 (2012).
19. Almahariq, M. et al. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol Pharmacol 83, 122-128 (2013).
20. Gong, B. et al. Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A 110, 19615-19620 (2013).
21. Almahariq, M. et al. Exchange Protein Directly Activated by cAMP (EPAC1) Modulates Regulatory T Cell-Mediated Immune Suppression. Biochem J 465, 295-303 (2015).
22. Rehmann, H. Epac-inhibitors: facts and artefacts. Sci Rep 3, 3032 (2013).
23. Das, R. et al. Dynamically driven ligand selectivity in cyclic nucleotide binding domains. J Biol Chem 284, 23682-23696 (2009).
24. Selvaratnam, R., Chowdhury, S., VanSchouwen, B. & Melacini, G. Mapping allostery through the covariance analysis of NMR chemical shifts. Proc Natl Acad Sci U S A 108, 6133-6138 (2011).
25. Selvaratnam, R. et al. The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants. Biophys J 102, 630-639 (2012).
26. Selvaratnam, R., Mazhab-Jafari, M. T., Das, R. & Melacini, G. The auto-inhibitory role of the EPAC hinge helix as mapped by NMR. PLoS One 7, e48707 (2012).
27. Bacallao, K. & Monje, P. V. Opposing roles of PKA and EPAC in the cAMP-dependent regulation of schwann cell proliferation and differentiation [corrected]. PLoS One 8, e82354 (2013).
28. Mediero, A., Perez-Aso, M. & Cronstein, B. N. Activation of EPAC1/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements. Faseb j 28, 4901-4913 (2014).
29. Li, X. et al. The adenylyl cyclase inhibitor MDL-12,330A potentiates insulin secretion via blockade of voltage-dependent K(+) channels in pancreatic beta cells. PLoS One 8, e77934 (2013).
30. Zhang, M. et al. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic beta cells. Mol Cell Proteomics 13, 3049-3062 (2014).
31. Aslam, M. et al. cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation. Physiol Rep 2, e12175 (2014).
32. Dawn, A. et al. The Central Role of cAMP in Regulating Plasmodium falciparum Merozoite Invasion of Human Erythrocytes. PLoS Pathog 10, e1004520 (2014).
33. Ivonnet, P., Salathe, M. & Conner, G. E. Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling. Br J Pharmacol 172, 173-184 (2015).
34. Almahariq, M. et al. Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo. Mol Pharmacol 87, 142-149 (2015).
35. Chen, H. et al. Efficient Synthesis of ESI-09, A Novel Non-cyclic Nucleotide EPAC Antagonist. Tetrahedron Lett 54, 1546-1549 (2013).
36. Ding, C. et al. Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility. J Med Chem 56, 5048-5058 (2013).
37. Mei, F. C. & Cheng, X. Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton. Mol Biosyst 1, 325-331 (2005).
38. Li, S. et al. Mechanism of Intracellular cAMP Sensor Epac2 Activation cAMP-Induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Biol Chem 286, 17889-17897 (2011).
39. Tsalkova, T., Blumenthal, D. K., Mei, F. C., White, M. A. & Cheng, X. Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities. J Biol Chem 284, 23644-23651 (2009).
40. Niesen, F. H., Berglund, H. & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2, 2212-2221 (2007).
41. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277-293 (1995).
42. Goddard, T. D. & Kneller, D. G. SPARKY (University of California, San Francisco).